NFKB1 and breast carcinoma: Organic components such as 6-methoxymellein, anthocyanins, pterostilbene, eugenol, tanshinone IIA, sulforaphane, and machilin D are capable to inhibit NF-κB-induced BCSCs and drug resistance in breast cancer (Lin et al., 2013; Mak et al., 2013; Burnett et al., 2017; Islam et al., 2018; Liu R. et al., 2020; Paramanantham et al., 2020; Zhen et al., 2020).